Chemodex

Forskolin

CHF 135.00
In stock
CDX-F0167-M01010 mgCHF 135.00
CDX-F0167-M02525 mgCHF 285.00
CDX-F0167-M05050 mgCHF 489.00
More Information
Product Details
Synonyms Boforsin; Colforsin; Coleonol; NSC 357088; NSC 375489; HL 362; L 75-1362B
Product Type Chemical
Properties
Formula

C22H34O7

MW 410.5
CAS 66575-29-9
RTECS QL6150000
Source/Host Chemicals Plant
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in DMSO, DMF or ethanol.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key OHCQJHSOBUTRHG-KGGHGJDLSA-N
Smiles C=C[C@](C1)(C)O[C@]2(C)[C@@H](OC(C)=O)[C@@H](O)[C@@]3([H])C(C)(C)CC[C@H](O)[C@]3(C)[C@@]2(O)C1=O
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +20°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at RT.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Forskolin is a naturally occurring diterpene. It directly activates adenylyl cyclase through its catalytic subunit and is commonly used to raise levels of cAMP (an important signal carrier necessary for the proper biological response of cells to hormones, neurotransmitters, and other extracellular signals) in a wide variety of intact cells and tissue preparations. Forskolin also interacts with glucose transporters and certain ion channels and has been used for examining adenylyl cyclase expression, regulation, and G protein signaling. Forskolin is a smooth muscle relaxant/vasodilator with inotropic and antihypertensive activity. Forskolin has antioxidant and anti-inflammatory property and reduces hyperglycemia by stimulating insulin release. It has anti-neuroinflammatory and neuroprotective properties that ameliorates Alzheimer’s disease symptoms and has also shown a number of antitumor effects.

Product References

(1) H. Metzger & E. Lindner; Arzneimittelforschung 31, 1248 (1981) | (2) K.B. Seamon & J.W. Daly; J. Cyclic Nucleotide Res. 7, 201 (1981) | (3) N.J. de Souza, et al.; Med. Res. Rev. 3, 201 (1983) | (4) H.G. Joost & H.J. Steinfelder; Mol. Pharmacol. 31, 279 (1987) | (5) A. Laurenza, et al.; TIPS 10, 442 (1989) (Review) | (6) M.L. Aylwin & M.M. White; Mol. Pharmacol. 41, 908 (1992) | (7) P.J. Scarpace & M. Matheny; Pflugers Arch. 431, 388 (1996) | (8) P.A. Insel & R.S. Ostrom; Cell Mol. Neurobiol. 23, 305 (2003) | (9) N. Canu, et al.; J. Neurochem. 92, 1228 (2005) | (10) H. Yamanaka, et al.; Mol. Med. Rep. 3, 133 (2010) | (11) R.H. Alasbahi & M.F. Melzig; Pharmazie 67, 5 (2012) (Review) | (12) V.D. Wagh, et al.; J. Postgrad. Med. 58, 199 (2012) (Review) | (13) B.A. Owona, et al.; J. Neuropathol. Exp. Neurol. 75, 618 (2016) | (14) L. Sapio, et al.; J. Cell Physiol. 232, 922 (2017) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.